244 related articles for article (PubMed ID: 9643442)
1. Interspecies scaling: predicting volumes, mean residence time and elimination half-life. Some suggestions.
Mahmood I
J Pharm Pharmacol; 1998 May; 50(5):493-9. PubMed ID: 9643442
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetic principles behind scaling from preclinical results to phase I protocols.
Mahmood I; Balian JD
Clin Pharmacokinet; 1999 Jan; 36(1):1-11. PubMed ID: 9989339
[TBL] [Abstract][Full Text] [Related]
3. Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species.
Riviere JE; Martin-Jimenez T; Sundlof SF; Craigmill AL
J Vet Pharmacol Ther; 1997 Dec; 20(6):453-63. PubMed ID: 9430769
[TBL] [Abstract][Full Text] [Related]
4. Towards a better prediction of peak concentration, volume of distribution and half-life after oral drug administration in man, using allometry.
Sinha VK; Vaarties K; De Buck SS; Fenu LA; Nijsen M; Gilissen RA; Sanderson W; Van Uytsel K; Hoeben E; Van Peer A; Mackie CE; Smit JW
Clin Pharmacokinet; 2011 May; 50(5):307-18. PubMed ID: 21456631
[TBL] [Abstract][Full Text] [Related]
5. Preclinical pharmacokinetics of MI-219, a novel human double minute 2 (HDM2) inhibitor and prediction of human pharmacokinetics.
Zou P; Zheng N; Yu Y; Yu S; Sun W; McEachem D; Yang Y; Yu LX; Wang S; Sun D
J Pharm Pharm Sci; 2012; 15(2):265-80. PubMed ID: 22579006
[TBL] [Abstract][Full Text] [Related]
6. Prediction of human oral plasma concentration-time profiles using preclinical data: comparative evaluation of prediction approaches in early pharmaceutical discovery.
Van den Bergh A; Sinha V; Gilissen R; Straetemans R; Wuyts K; Morrison D; Bijnens L; Mackie C
Clin Pharmacokinet; 2011 Aug; 50(8):505-17. PubMed ID: 21740074
[TBL] [Abstract][Full Text] [Related]
7. Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: a comparative study.
Mahmood I
J Pharm Pharmacol; 1999 Aug; 51(8):905-10. PubMed ID: 10504028
[TBL] [Abstract][Full Text] [Related]
8. Modelling concentrations of antimicrobial drugs: comparative pharmacokinetics of cephalosporin antimicrobials and accuracy of allometric scaling in food-producing and companion animals.
Taverne FJ; van Geijlswijk IM; Heederik DJ; Wagenaar JA; Mouton JW
BMC Vet Res; 2016 Sep; 12(1):185. PubMed ID: 27596044
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach.
Mahmood I
Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species.
Hutchaleelaha A; Chow HH; Mayersohn M
J Pharm Pharmacol; 1997 Feb; 49(2):178-83. PubMed ID: 9055191
[TBL] [Abstract][Full Text] [Related]
11. Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance.
Mahmood I; Balian JD
J Pharm Sci; 1996 Apr; 85(4):411-4. PubMed ID: 8901079
[TBL] [Abstract][Full Text] [Related]
12. Animal pharmacokinetics and interspecies scaling from animals to man of lamifiban, a new platelet aggregation inhibitor.
Lave T; Saner A; Coassolo P; Brandt R; Schmitt-Hoffmann AH; Chou RC
J Pharm Pharmacol; 1996 Jun; 48(6):573-7. PubMed ID: 8832489
[TBL] [Abstract][Full Text] [Related]
13. Inter-species extrapolation of pharmacokinetic data of three prostacyclin-mimetics.
Hildebrand M
Prostaglandins; 1994 Nov; 48(5):297-312. PubMed ID: 7531864
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic allometric scaling of coagulation factors and tissue-type plasminogen activators.
Mahmood I
Haemophilia; 2009 Sep; 15(5):1109-17. PubMed ID: 19523109
[TBL] [Abstract][Full Text] [Related]
15. Application of allometric principles for the prediction of pharmacokinetics in human and veterinary drug development.
Mahmood I
Adv Drug Deliv Rev; 2007 Sep; 59(11):1177-92. PubMed ID: 17826864
[TBL] [Abstract][Full Text] [Related]
16. Interspecies scaling of interferon disposition and comparison of allometric scaling with concentration-time transformations.
Lave T; Levet-Trafit B; Schmitt-Hoffmann AH; Morgenroth B; Richter W; Chou RC
J Pharm Sci; 1995 Nov; 84(11):1285-90. PubMed ID: 8587044
[TBL] [Abstract][Full Text] [Related]
17. Allometric scaling of marbofloxacin pharmacokinetics: a retrospective analysis.
Yohannes S; Hossain MA; Kim JY; Lee SJ; Kwak DM; Suh JW; Park SC
Pol J Vet Sci; 2014; 17(1):99-103. PubMed ID: 24724476
[TBL] [Abstract][Full Text] [Related]
18. Drug disposition viewed in terms of the fractal volume of distribution.
Karalis V; Macheras P
Pharm Res; 2002 May; 19(5):696-703. PubMed ID: 12069175
[TBL] [Abstract][Full Text] [Related]
19. Prediction of the pharmacokinetic parameters of reduced-dolasetron in man using in vitro-in vivo and interspecies allometric scaling.
Sanwald-Ducray P; Dow J
Xenobiotica; 1997 Feb; 27(2):189-201. PubMed ID: 9058532
[TBL] [Abstract][Full Text] [Related]
20. Quantitative structure-activity relationship models of clinical pharmacokinetics: clearance and volume of distribution.
Gombar VK; Hall SD
J Chem Inf Model; 2013 Apr; 53(4):948-57. PubMed ID: 23451981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
